A promising future for hypothalamic dysfunction in craniopharyngioma
Neuro Oncol
.
2023 Apr 6;25(4):733-734.
doi: 10.1093/neuonc/noac284.
Authors
John Richard Apps
1
2
3
,
Juan Pedro Martinez-Barbera
2
Affiliations
1
Institute of Cancer and Genomics Sciences, University of Birmingham, Edgbaston Campus, Birmingham, B15 2TT, UK.
2
Developmental Biology and Cancer, Birth Defects Research Centre, GOS Institute of Child Health, University College London, WC1N 1EH, London, UK.
3
Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
PMID:
36573374
PMCID:
PMC10076929
DOI:
10.1093/neuonc/noac284
No abstract available
Publication types
Editorial
Comment
MeSH terms
Craniopharyngioma*
Humans
Hypothalamus / physiopathology
Lipids
Obesity
Pituitary Neoplasms*
Substances
Lipids
Grants and funding
27727/CRUK_/Cancer Research UK/United Kingdom
28160/CRUK_/Cancer Research UK/United Kingdom
MR/M000125/1/MRC_/Medical Research Council/United Kingdom